Catalyst Wire Dossier Catalyst Wire Dossier

Aprocitentan

aprocitentan · Idorsia Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Aprocitentan, covering 2022-11-23 to 2025-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives [Phase 1]

See pricing